BPC-157 + TB-500 + KPV + GHK-Cu (Klow Blend), 10/10/10/40mg

The KLOW Blend is a comprehensive recovery-focused peptide formulation designed to target inflammation, accelerate tissue repair, and promote cellular regeneration.
BPC-157, TB-500, KPV, and GHK-Cu are not FDA-approved and are classified as research peptides. This content is intended for educational and informational purposes only.

What is BPC-157 + TB-500 + KPV + GHK-Cu (Klow Blend), 10/10/10/40mg?

The KLOW Blend is a multi-peptide formulation designed to support comprehensive recovery, inflammation control, and tissue regeneration. It combines BPC-157, a synthetic peptide derived from a protein in gastric juice that’s studied for its ability to promote healing in muscles, tendons, ligaments, joints, and the gastrointestinal lining; TB-500, a thymosin beta-4 fragment known for enhancing cell migration, blood vessel growth, and tissue repair; KPV, a tripeptide with strong anti-inflammatory properties explored for its effects on cytokine regulation and immune balance; and GHK-Cu, a naturally occurring copper-binding peptide researched for its role in skin regeneration, wound healing, collagen synthesis, and antioxidant activity. Together, these peptides form a synergistic blend that targets multiple biological pathways involved in soft tissue healing, immune modulation, and cellular repair.


Potential Benefits Shown in Studies

Possible benefits of the KLOW blend:

  • Accelerated healing of soft tissue, including muscles, tendons, ligaments, and skin
  • Reduced systemic and localized inflammation through immune-modulating pathways
  • Enhanced angiogenesis to improve blood flow and nutrient delivery to damaged tissues
  • Improved tissue regeneration and remodeling with support for scar minimization
  • Gut barrier protection and anti-inflammatory effects in gastrointestinal tissues
  • Increased collagen synthesis and skin repair via copper peptide signaling
  • Support for nerve regeneration and protection against oxidative stress
  • Synergistic multi-pathway recovery—targeting inflammation, repair, and remodeling concurrently

Mechanisms of Action

BPC-157

  • Upregulates growth factors like VEGF and FGF for tissue repair
  • Enhances fibroblast activity and tendon fibrocyte migration
  • Stabilizes nitric oxide pathways and protects endothelium
  • Promotes angiogenesis and collagen formation at injury sites

TB-500

  • Binds G-actin to regulate cytoskeleton dynamics and cell movement
  • Stimulates angiogenesis via VEGF modulation
  • Promotes wound healing by activating regenerative gene expression
  • Enhances satellite cell recruitment in muscle repair

KPV

  • Modulates inflammatory cytokines by downregulating NF-κB activity
  • Acts on melanocortin 1 receptor (MC1R) to suppress local inflammation
  • Reduces intestinal and skin inflammation in preclinical models
  • Inhibits pro-inflammatory mediators like TNF-α and IL-6

GHK-Cu

  • Activates genes related to tissue remodeling, wound healing, and antioxidant defense
  • Increases synthesis of collagen, elastin, and glycosaminoglycans
  • Promotes angiogenesis and blood vessel repair via copper ion transport
  • Protects against oxidative stress and supports DNA repair enzymes
This blend contains

Research Highlights

Research on

BPC-157

Accelerated Musculoskeletal Healing & Regeneration

Preclinical studies show BPC‑157 markedly enhances repair of tendons, ligaments, muscles, nerves, bones, and vascular tissues in animal models by promoting angiogenesis, collagen synthesis, and fibroblast activity.

Source: springer

Mechanistic Insight: Pathways of Repair and Neuroprotection

BPC‑157 appears to act through multiple pathways including VEGF, nitric oxide signaling, and ERK1/2, leading to improved angiogenesis, reduced oxidative stress, neuromuscular stability, and protection against neurotransmitter imbalances in rodents.

Source: springer

Robust Tendon & Ligament Repair

Rodent models demonstrate that BPC‑157 accelerates healing of Achilles tendon and MCL injuries through aligned collagen fiber formation, increased fibroblast proliferation, and improved structural integrity.

Source: drdavidgeier
Research on

TB-500

Actin Regulation & Cellular Repair Activation

TB‑500 influences cytoskeletal dynamics by binding to actin monomers (G-actin), promoting cell mobility and facilitating critical steps in tissue repair.

Source: Lotilabs Research Review

Preclinical Tissue Regeneration & Anti-inflammatory Actions

Animal studies demonstrate that TB‑500 accelerates wound healing, encourages blood vessel formation (angiogenesis), and mitigates inflammation, supporting recovery across multiple tissue types.

Source: Breaking AC Research Overview

Clinical Insights from Thymosin β‑4 Trials

Clinical studies with native thymosin β‑4 (Tβ4) have shown accelerated healing of pressure ulcers and corneal injuries, indicating translational potential for TB‑500 in human tissue repair.

Source: Wikipedia Clinical Overview of Thymosin β‑4
Research on

GHK-Cu (Copper Peptide)

Skin Repair and Anti-Aging

Topical application of GHK-Cu has been shown to reduce wrinkles, improve skin elasticity, and enhance firmness by increasing collagen, glycosaminoglycans, and fibroblast activity.

Source: pubmed

Wound Healing and Tissue Regeneration

GHK-Cu accelerates wound closure and reduces scar formation by promoting angiogenesis, immune regulation, and tissue matrix rebuilding.

Source: pubmed

Hair Growth Stimulation

Research supports GHK-Cu's ability to stimulate hair regrowth, likely due to its effects on follicle enlargement, stem cell activation, and improved scalp circulation.

Source: pubmed

Molecular Structure

BPC-157

Sequence

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular Formula

C₆₂H₉₈N₁₆O₂₂

Molecular Weight

1419.556 g/mol

Source
PubChem

TB-500

Sequence

Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser

Molecular Formula

C₂₁₂H₃₅₀N₅₆O₇₈S

Molecular Weight

4963.49 g/mol

Source
PubChem

GHK-Cu (Copper Peptide)

Sequence

Gly-His-Lys (with bound Cu²⁺)

Molecular Formula

C₁₄H₂₄CuN₆O₄

Molecular Weight

340.9 g/mol

Source
PubChem

Sources